Avantor: The Q4 Dip Could Have Priced In All The Negatives
Avantor is a turnaround play in life sciences distribution and manufacturing, trading at a historically low valuation after a 50% stock decline. New management is executing a Revival program targeting $400M in cost savings, debt reduction, and organizational restructuring to restore growth and margins. 2026 guidance remains cautious, with revenue and adjusted EPS expected to decline, but stabilization and growth are anticipated in 2027.
New Strong Sell Stocks for February 17th
AVTR, CMCO and KHC have been added to the Zacks Rank #5 (Strong Sell) List on February 17th, 2026.
AVTR Stock Plunges Despite Q4 Earnings Beat Estimates, Margins Decline
Avantor stock sinks 13% as Q4 earnings beat estimates, but revenues slip, margins contract and 2026 outlook signals more pressure ahead.
Avantor, Inc. (AVTR) Q4 2025 Earnings Call Transcript
Avantor, Inc. (AVTR) Q4 2025 Earnings Call Transcript
Avantor (AVTR) Q4 Earnings: Taking a Look at Key Metrics Versus Estimates
Although the revenue and EPS for Avantor (AVTR) give a sense of how its business performed in the quarter ended December 2025, it might be worth considering how some key metrics compare with Wall Street estimates and the year-ago numbers.
Avantor, Inc. (AVTR) Surpasses Q4 Earnings and Revenue Estimates
Avantor, Inc. (AVTR) came out with quarterly earnings of $0.22 per share, beating the Zacks Consensus Estimate of $0.21 per share. This compares to earnings of $0.27 per share a year ago.
Should Value Investors Buy Avantor (AVTR) Stock?
Here at Zacks, our focus is on the proven Zacks Rank system, which emphasizes earnings estimates and estimate revisions to find great stocks. Nevertheless, we are always paying attention to the latest value, growth, and momentum trends to underscore strong picks.
AVTR or ALHC: Which Is the Better Value Stock Right Now?
Investors interested in stocks from the Medical Services sector have probably already heard of Avantor, Inc. (AVTR) and Alignment Healthcare (ALHC). But which of these two stocks offers value investors a better bang for their buck right now?
Avantor, Inc. (AVTR) Presents at 44th Annual J.P. Morgan Healthcare Conference Transcript
Avantor, Inc. (AVTR) Presents at 44th Annual J.P. Morgan Healthcare Conference Transcript
Here's Why You Should Hold Avantor Stock in Your Portfolio for Now
AVTR looks worth holding as its broad portfolio, strategic deals and cost savings offset Lab Solutions' weakness for now with AI tools and strong cash flow.
New Strong Sell Stocks for Dec. 24
Here are three stocks added to the Zacks Rank #5 (Strong Sell) List today:
New Strong Sell Stocks for Dec. 22
Here are three stocks added to the Zacks Rank #5 (Strong Sell) List today:
